Ruđer Bošković Institute and Sestre milosrdnice University Hospital Center have been granted access to HPC Vega supercomputer for prostate cancer research through a public EuroHPC JU Access Call

A team of Croatian researchers has been granted new access to HPC Vega for cancer research.

New access to HPC Vega is granted for cancer research using the Vini biophysical model of cancer. Research will be performed by a team of researchers at the Ruđer Bošković Institute, Center for Informatics and Computing, and the Sestre milosrdnice University Hospital Center, jointly led by Prof. Dr. Ana Fröbe and Dr. Draško Tomić. Access was obtained through a public EuroHPC JU Access Call.

HPC Vega is located at the Institute of Information Sciences – IZUM in Maribor, Slovenia. With 960 CPU nodes (overall 1920 CPUs AMD Epyc 7H12 – 122.000 cores) and 60 GPU nodes (overall 240 GPUs NVidia A100) the sustained performance of HPC Vega is 6.9 PFLOPS (peak performance is 10.1 PFLOPS). An access request was granted for a period of 12 months, starting on March 8, 2023. Allocated resources are 10.000.000 core hours on the HPC Vega CPU partition.

The research team will use these resources in their search for better therapies against prostate cancer.